Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

SELL
$12.55 - $17.22 $4.42 Million - $6.06 Million
-351,888 Reduced 19.0%
1,500,524 $25.3 Million
Q4 2023

Feb 14, 2024

SELL
$9.64 - $14.59 $486,154 - $735,788
-50,431 Reduced 2.65%
1,852,412 $26.2 Million
Q3 2023

Nov 14, 2023

BUY
$10.3 - $15.99 $242,050 - $375,765
23,500 Added 1.25%
1,902,843 $19.6 Million
Q1 2023

May 15, 2023

BUY
$6.41 - $9.95 $8.12 Million - $12.6 Million
1,266,202 Added 206.51%
1,879,343 $17.2 Million
Q4 2022

Feb 14, 2023

BUY
$5.02 - $10.0 $2.59 Million - $5.16 Million
516,235 Added 532.72%
613,141 $4.39 Million
Q3 2022

Nov 14, 2022

SELL
$2.57 - $7.31 $3.83 Million - $10.9 Million
-1,488,386 Reduced 93.89%
96,906 $485,000
Q2 2022

Aug 15, 2022

SELL
$1.07 - $6.95 $567,888 - $3.69 Million
-530,737 Reduced 25.08%
1,585,292 $3.87 Million
Q1 2022

May 16, 2022

SELL
$5.46 - $8.29 $802,472 - $1.22 Million
-146,973 Reduced 6.49%
2,116,029 $14.5 Million
Q4 2021

Feb 14, 2022

BUY
$7.34 - $11.18 $3.93 Million - $5.99 Million
535,942 Added 31.03%
2,263,002 $18.3 Million
Q3 2021

Nov 15, 2021

BUY
$6.49 - $9.91 $9.7 Million - $14.8 Million
1,494,523 Added 642.7%
1,727,060 $16.9 Million
Q2 2021

Aug 16, 2021

BUY
$6.73 - $9.05 $1.56 Million - $2.1 Million
232,537 New
232,537 $1.57 Million

Others Institutions Holding AVDL

About AVADEL PHARMACEUTICALS PLC


  • Ticker AVDL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 60,581,300
  • Market Cap $662M
  • Description
  • Avadel Pharmaceuticals plc operates as a biopharmaceutical company in the United States. Its lead product candidate is FT218, a formulation of sodium oxybate, which is in a Phase 3 clinical trial for the treatment of excessive daytime sleepiness and cataplexy in adults with narcolepsy. The company was formerly known as Flamel Technologies SA and...
More about AVDL
Track This Portfolio

Track Woodline Partners LP Portfolio

Follow Woodline Partners LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Woodline Partners LP, based on Form 13F filings with the SEC.

News

Stay updated on Woodline Partners LP with notifications on news.